학술논문
Neuropsychological outcome after chemotherapy for primary CNS lymphoma
Document Type
Article
Author
Source
Neurology (Ovid); April 2005, Vol. 64 Issue: 7 p1184-1188, 5p
Subject
Language
ISSN
00283878; 1526632X
Abstract
Combined radio- and chemotherapy for primary CNS lymphoma (PCNSL) is associated with a considerable risk of long-term neurotoxicity. The impact of high-dose methotrexate (MTX)-based chemotherapy alone on cognition and quality of life (QOL) is controversial.